US Patent 7175855 Ziprasidone suspension
Patent 7175855 was granted and assigned to Pfizer on February, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+291 characters)
Article
Patent abstract
Compositions comprising ziprasidone free base or a difficult to wet pharmaceutically acceptable ziprasidone acid addition salt, a polysorbate, and colloidal silicon dioxide form good aqueous suspensions having a useful shelf life and are easily re-suspended if setting occurs.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07175855 Ziprasidone suspension US Patent 7175855 Ziprasidone suspension
Infobox
Patent Number
0717585500
Patent Number
717585500
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071758550
Date of Patent
February 13, 2007
0Patent Application Number
095733120
Date Filed
May 18, 2000
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071758550
Date of Patent
February 13, 2007
0Patent Application Number
095733120
Date Filed
May 18, 2000
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 20 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07175855 Ziprasidone suspension
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07175855
Date of patent
February 13, 2007
Patent application number
09573312
Date Filed
May 18, 2000
Patent primary examiner
Find more entities like US Patent 7175855 Ziprasidone suspension
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.